GET DAILY SIGNALSGlass House Brands (GLAS) Drops -57% in 30 Days: Analyzing the Recent Sell-Off
Key Takeaways
- Glass House Brands (GLAS) declined roughly 57% over the trailing 30 days, falling from about $5.49 to around $2.39 per share.
- The sell-off accelerated after preliminary third-quarter results pointed to a lower expected average selling price of approximately $150 per pound.
- Soft California wholesale cannabis pricing, margin compression, and an unfavorable trim-heavy product mix weighed on results and sentiment.
- A planned chief financial officer transition and an auditor change added governance-related uncertainty during the period.
- The stock is down roughly 76% over the last quarter and traded near a 52-week low of $1.67 in mid-October.
- Analysts have maintained broadly positive ratings but have cut price targets sharply amid the decline.
Glass House Brands (GLAS) Overview and Market Position
Glass House Brands Inc. is a vertically integrated cannabis company operating one of the largest greenhouse cultivation footprints in California. The business spans cultivation, production, and retail, and is classified within the Consumer Staples sector under the Tobacco sub-industry. Its shares trade on the NYSE under the ticker GLAS, with additional listings on the NEO exchange and OTCQX.
The company's investment case centers on its low-cost greenhouse production model and scale advantages in the competitive California wholesale flower market. In the second quarter of 2026, Glass House produced a record 246,000 pounds of biomass and reported a production cost of $122 per pound, down from $175 per pound in the first quarter, while targeting a full-year output of roughly one million pounds and a long-term cost goal of $95 per pound. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Investors follow the stock closely because of this cost-driven scale strategy and its exposure to evolving U.S. cannabis regulation.
Glass House Brands (GLAS) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, GLAS fell from a closing price of approximately $5.49 to around $2.39, a decline of about 57%. The decline was not uniform: the shares held near the $5 level through early October before breaking down sharply, with single-day moves accelerating in mid-October as selling pressure intensified.
The quarterly trend has been even steeper. From roughly $10.06 in early August, the stock has dropped about 76% to its current level, and it traded as low as $1.67 on October 19, 2026. From its 52-week high of $13.19, the shares have declined more than 80%. This sustained downtrend reflects a combination of weakening fundamentals, sector-wide cannabis weakness, and a rapid repricing of the stock's growth expectations.
What Drove GLAS Stock Price in the Last 30 Days
The most consequential catalyst was the company's preliminary third-quarter update, which signaled that its average selling price would fall to roughly $150 per pound, down from $211 per pound in the second quarter. While revenue guidance of about $56.8 million came in ahead of analyst expectations, the pricing disclosure underscored ongoing margin pressure, and the shares fell sharply in response.
Additional factors compounded the decline. Lake Street lowered its price target to $7 from $17 while keeping a Buy rating, citing softer pricing, an unfavorable product mix, and a more gradual margin recovery. The company also announced GACP certification for its Casitas and Padaro greenhouses, a step toward potential international medical markets; however, the news carried no immediate revenue impact because export is contingent on future regulatory approvals, and the stock declined following the announcement.
Technically, the shares broke below key moving averages and reached a 52-week low of $1.67 on elevated volume, reflecting what market commentary described as broad capitulation and a lack of near-term positive catalysts.
What Drove GLAS Stock Performance Over the Last Quarter
The broader quarterly decline traces back to disappointing fiscal second-quarter results reported in August. Revenue of $47.0 million missed expectations, gross margin fell to 34% from 55% a year earlier, and adjusted EBITDA declined to $5.7 million from $18.1 million. Management attributed the margin compression to an unfavorable trim mix, a less experienced workforce, and a temporary cogeneration outage, and withdrew formal guidance while assessing regulatory developments.
Governance changes also weighed on sentiment. The company announced the planned retirement of its CFO and completed a change in its independent auditor. These transitions, combined with share dilution from accelerated warrant expiries, soft California wholesale pricing, and continued uncertainty around federal cannabis rescheduling and the IRS Section 280E tax burden, contributed to a sustained repricing of the stock throughout the quarter.
GLAS Stock Forecast Drivers: What Investors Should Watch Next
Looking ahead, investors are likely to monitor several factors. The most immediate is the company's next earnings release and any updated guidance on average selling prices, gross margin, and its full-year production target of roughly one million pounds. Progress on lowering production costs toward management's sub-$100-per-pound objective will be central to the profitability narrative.
Beyond operations, watch for developments on wholesale cannabis pricing in California, the normalization of the product mix away from lower-value trim, and the completion of the CFO succession process. On the regulatory front, the timeline for federal cannabis rescheduling and any changes to Section 280E tax treatment, as well as any pathway to international export enabled by GACP certification, remain important catalysts. These factors carry meaningful uncertainty, and the stock's performance will likely remain sensitive to how each evolves. From what I see, this is important because regulatory shifts could alter the trajectory significantly.
Using Tickeron AI Tools in My Research
In my analysis, I frequently consult Tickeron’s Trending AI Robots page to evaluate automated strategies that might align with opportunities like this. The platform provides insights into various bots and their performance, helping me stay informed on market trends without constant monitoring. It offers a curated selection of AI-driven trading bots across different strategies and timeframes, allowing for better comparison of approaches.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
GLAS's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for GLAS turned positive on October 28, 2026. Looking at past instances where GLAS's MACD turned positive, the stock continued to rise in 28 of 36 cases over the following month. The odds of a continued upward trend are 78%.
Technical Analysis (Indicators)
Bullish Trend Analysis
GLAS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLAS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for GLAS entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.829) is normal, around the industry mean (8.329). P/E Ratio (-2.868) is within average values for comparable stocks, (-1.568). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (3.880) is also within normal values, averaging (178.797).
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. GLAS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLAS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PharmaceuticalsGeneric
Advertisement